EUVIMEDEUVIMED entdecken
Crossref

Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors

Thomas S Weiss, Christa Buechler

Anticancer Research · 2025

DOI: 10.21873/anticanres.17504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Thomas S Weiss und 1 weiteren Autor:innen. Beteiligte Einrichtung: Children's University Hospital (KUNO), Regensburg University Hospital, Regensburg, Germany. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Colorectal Neoplasms, Proprotein Convertase 9. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsColorectal NeoplasmsProprotein Convertase 9Case-Control StudiesHumansMaleFemaleAdultAgedAged, 80 and overBiomarkers, TumorHypercholesterolemiaNeoplasm Metastasis

Stichwörter der Autor:innen

Hepatocellular carcinomacolorectal cancerhypercholesterolemia

Substanzen

PCSK9 protein, humanProprotein Convertase 9Biomarkers, Tumor

Autor:innen und Institutionen

  • Children's University Hospital (KUNO), Regensburg University Hospital, Regensburg, Germany.
  • Department of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany christa.buechler@ukr.de.

Zitieren

APA

Weiss, T. S., & Buechler, C. (2025). Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors. Anticancer Research. https://doi.org/10.21873/anticanres.17504

Vancouver

Weiss TS, Buechler C. Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors. Anticancer Research. 2025. doi:10.21873/anticanres.17504

BibTeX
@article{Weiss2025,
  author = {Weiss, Thomas S and Buechler, Christa},
  title = {Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic Patients With Primary and Metastatic Liver Tumors},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17504}
}
Kostenlos starten →